Trial · NCT06302998
Dexmedetomidine and Vasopressin in Septic Shock
NCT06302998, Phase 2, Unknown, Mansoura University
3 sourcestrials-2026-11-12-0.5.0
Cite this record
ConductScience Library. Dexmedetomidine and Vasopressin in Septic Shock. Trials, record NCT06302998. Release trials-2026-11-12-0.5.0, 12 Nov 2026. https://conductscience.org/library/trials/NCT06302998
On this page
Trial
As registered on ClinicalTrials.gov, in the graph's capture of the registry.
- Title
- Dexmedetomidine and Vasopressin in Septic Shock
- NCT number
- NCT06302998
- Status
- Unknown
- Phases
- Phase 2
- Enrollment
- 260 participants, estimated
- Lead sponsor
- Mansoura University
- Conditions
- Sepsis, Septic Shock
- Interventions
- DEX-PRESSIN, Standard of Care
- First posted
- 2024-03-12
- Last updated
- 2024-03-12
Source ClinicalTrials.gov
Registered outcomes12
Each outcome the trial registered, primary first, in ClinicalTrials.gov's words.
| List | Outcome | Time frame | Description |
|---|---|---|---|
| Primary | in-hospital mortality | throughout the hospitalization period on average 90 days. | All-cause inhospital mortality as a binary outcome |
| Secondary | survival analysis | through out the hospitalization period or 28 days after inclusion if discharged from hosptia; before 28 days | time to die using Kaplan Mier Curve |
| Secondary | Norepinephrine Equivalent Dose (NED) | over the first three days after enrolment or death | mean NED over the first three days after enrolment or death, whichever comes first; the NED of epinephrine will be estimated as a 1:1 ratio |
| Secondary | Duration of vasopressor infusion in survivors | through out the hospitalization period or 28 days after inclusion if discharged from hosptial before 28 days | Duration in hours from the start of the vasopressor (NE or vasopressin) infusion till the time of discontinuation. |
| Secondary | Initiation of invasive mechanical ventilation (IMV) | through out the hospitalization period or 28 days after inclusion if discharged from hosptial before 28 days | incidence of IMV |
| Secondary | Duration of IMV | through out the hospitalization period or 28 days after inclusion if discharged from hosptial before 28 days | duratioin in hours |
| Secondary | Early acute kidney injury (AKI) | within 48 hours | AKI according to the KDIGO guidelines 2012 |
| Secondary | Late acute kidney injury (AKI) | between 48 hours and 7 days | AKI according to the KDIGO guidelines 2012 |
| Secondary | Acute Physiology and Chronic Health Evaluation (APACHE-II) | on the 3rd day after enrollment | As a score on MedCalc |
| Secondary | Simplified Acute Physiology Score (SAPS) II score | on the 3rd day after enrollment | As a score on MedCalc |
1 to 10 of 12Source ClinicalTrials.gov
See all 12 registered outcomesOutcomes0
Each outcome the trial posted results for, in ClinicalTrials.gov's words.
None in this release.
Results by group0
Each measurement the trial posted, group by group, in the words and numbers it posted.
None in this release.
Participant flow0
How many started, completed or left each group, period by period.
None in this release.
Adverse events0
Each adverse event the trial posted, group by group: the participants affected out of those at risk.
None in this release.
Adverse event totals0
The totals the trial posted for each group.
None in this release.
Papers0
The papers the trial lists on ClinicalTrials.gov.
None in this release.
Grants0
The grants NIH RePORTER links to the trial, newest funded first: NIH's, and some of AHRQ's, CDC's, FDA's and VA's. Each shows its title, principal investigators, organization and funder in its newest year.
None in this release.
Trial comparisons0
Comparisons of the trial's two groups, calculated by ConductScience from the counts it posted.
None in this release.
Tests0
The ConductCognition tests this trial's registered outcomes name, as ScienceGraph matched them in trial-tests-2026-11-12-0.2.1.
None in this release.
Data dates
The day each source was copied for this release.
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this trial from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/trials/v1/NCT06302998
GET https://conductscience.org/api/trials/v1/NCT06302998/registered